LIF and ovarian carcinoma: These infiltrated MSCs were described as having a role to play in ovarian cancer progression by releasing IL-6, CXCR1/2 ligands (CXCL1, CXCL2, and IL-8), and related cytokine leukemia inhibitory factor (LIF) [167,169].